Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients.

Wand, Ori; Dahan, David; Tov, Naveh; Epstein Shochet, Gali; King, Daniel A; Shitrit, David

Wand, Ori; Dahan, David; Tov, Naveh; Epstein Shochet, Gali; King, Daniel A; Shitrit, David.

Wand O; Department of Pulmonary Medicine, Meir Medical Center, Kfar Saba, Israel.
Dahan D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tov N; Department of Pulmonary Medicine, Meir Medical Center, Kfar Saba, Israel.
Epstein Shochet G; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
King DA; Department of Clinical Development, Kamada Ltd, Rehovot, Israel.
Shitrit D; Department of Pulmonary Medicine, Meir Medical Center, Kfar Saba, Israel.

Isr Med Assoc J ; 24(7): 441-443, 2022 07.

Article in English | MEDLINE | ID: covidwho-1929555

Subject(s)

COVID-19; alpha 1-Antitrypsin Deficiency; Critical Illness/therapy; Humans; alpha 1-Antitrypsin Deficiency/complications; alpha 1-Antitrypsin Deficiency/drug therapy

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Alpha 1-Antitrypsin Deficiency / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Isr Med Assoc J Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Israel

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links